Last updated: 2026-09-08 09:47:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Adagio Medical Holdings, Inc. (ADGM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0,58, with a market capitalization of $12,53M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,36 to $2,58. This page covers its latest market performance, valuation, price trends and company information.
$12,53M | |
$0,56 | |
$9,34 | |
$0,36 | |
-- | |
108,00 | |
8,17M | |
-- | |
$2,58 | |
$0,36 | |
-- | |
-- |
Adagio Medical Holdings, Inc. (ADGM) is trading at $0,54 in pre-market trading as of 2026-09-08 08:30:00, -- from the previous close of $0,00
Pre-market trading shows how investors are pricing ADGM before the regular session opens. The current pre-market price is -- the previous close, indicating positive early trading sentiment.
Over the past seven days, Adagio Medical Holdings, Inc. (ADGM) moved from $0,52 to $0,58, representing a gain of 11,09% ($0,06).
The stock traded between $0,49 and $0,59 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 188,06 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 9,7%
ADGM is currently trading at $0,58, placing it 9,7% of the way from its 52-week low of $0,36 to its 52-week high of $2,58. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 41 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Adagio Medical Holdings, Inc. (ADGM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.